Patent infringement actions filed by Pfizer Inc. against Teva
Pharmaceutical Industries and Actavis, Inc. relating to Neurontin
(gabapentin) were settled in May 2011.
Several years ago the Company filed patent-infringement actions…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.